Alterations in chromatin regulatory genes such as KDM6A, KMT2D, CREBBP, and EP300 are now recognized as critical contributors to tumor development, with mounting evidence that loss of histone modification and epigenetic control can enhance tumor plasticity, drive progression, and increase mutational burden [20]. This evidence concerns the gene CREBBP and neoplasm.